Finland· FI-REL-REL30873
Otrivin Comp
A xylometazoline product containing xylometazoline hydrochloride + ipratropium bromide, registered in Finland by Haleon Denmark ApS. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Xylometazoline is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Xylometazoline · ATC R01AB06
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Xylometazoline hydrochloride + Ipratropium bromide
- Manufacturer
- Haleon Denmark ApS
- Country
- Finland (FI)
- ATC code
- R01AB06
- ATC class
- Xylometazoline
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for xylometazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Xylometazoline · interactions on record
63 records
- 6 severe
- 54 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Xylometazoline in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandOtrivin ipra MAXInPharm Sp. z o.o.
- CzechiaOTRIVIN DUOHaleon Czech Republic s.r.o., Praha
- SwedenOtrivin Comp 0,5 mg/ml + 0,6 mg/ml Nässpray, lösningHaleon Denmark ApS
- NorwayOtrivin CompHaleon Denmark ApS
- IrelandOtrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml nasal spray, solutionHaleon Ireland Limited
- IcelandOtrivin CompHaleon Denmark ApS
- NetherlandsOtrivin Duo Xylometazolinehydrochloride & Ipratropiumbromide, 0,5/0,6 mg/ml, neusspray, oplossingHaleon Netherlands B.V.
- SpainRHINOVIN DUO 0,5 mg/ml + 0.6 mg/ml SOLUCION PARA PULVERIZACION NASALHaleon Spain S.A.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Otrivin Duo
- Belgium · Otrivine Duo
- Cyprus · Otrivin Advance
- Czechia · Otrivin Duo
- Denmark · Otrivin Comp, Zymelin Plus
- Estonia · Otrivin Total
- Spain · Rhinovin Duo
- United Kingdom (Northern Ireland) · Otrivine Extra Dual Relief
- Greece · Otrivin Advance
- Croatia · Ksilometazolinklorid/Ipratropijev Bromid Acino, Nasoryl
- Hungary · Otrivin Komplex
- Ireland · Otrivine Extra Dual Relief
- Iceland · Otrivin Comp
- Italy · Rinazina Doppia Azione
- Lithuania · Otriduo
- Luxembourg · Otrivine Duo
- Latvia · Otrivin Total
- Malta · Otrivine Extra Dual Relief
- Netherlands · Otrivin Duo
- Norway · Otrivin Comp, Zycomb
- Poland · Otrivin Ipra Max
- Portugal · Nasitrim Duoeffect, Vibrocil Actilongduo
- Romania · Rhinxyl Plus, Vibrocil Duo
- Sweden · Otrivin Comp, Zymelin Comp
- Slovenia · Maresyl Comb, Otrivin Duo
- Slovakia · Otrivin Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/426b2a08-d74f-4df2-847b-257143d1f7d7 GET /v1/drugs/426b2a08-d74f-4df2-847b-257143d1f7d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.8",
"form": "nenäsumute, liuos",
"route": "Nenään",
"ddd_unit": "ml",
"strength": "0.5 mg/ml + 0.6 mg/ml",
"atc_label": "ksylometatsoliini",
"ma_number": "24899",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL30873",
"authorised_at": "2008-12-15"
}See everything about xylometazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.